A Study of LY2409021 in Patients With Type 2 Diabetes

NCT01241448 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

263

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY2409021
DRUG: Placebo

Sponsor

Eli Lilly and Company